{
  "report_metadata": {
    "report_type": "Patient Accessibility Analysis",
    "condition": "Lung Cancer",
    "trial_type": "Interventional",
    "reporting_period": {
      "start_date": "2025-12-01",
      "end_date": "2025-12-31"
    }
  },
  "analysis_metrics": {
    "total_trials_analyzed": 73,
    "average_barrier_score": 1.37,
    "baseline_comparison": {
      "baseline": 1.15,
      "status": "High Selectivity",
      "delta": "+0.22"
    }
  },
  "highest_barrier_trial": {
    "nct_id": "NCT07300150",
    "barrier_score": 5.4,
    "title": "A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors",
    "facility_location": {
      "facility_name": "Dana-Farber/Massachusetts General Hospital, Inc",
      "city": "Boston",
      "state_province": "Massachusetts",
      "country": "United States"
    }
  }
}